EMERGENT BIOSOLUTIONS INC. Deferred Income Tax Expense (Benefit)
EMERGENT BIOSOLUTIONS INC. (EBS) reported Deferred Income Tax Expense (Benefit) of -$3.90 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-02-27
- EMERGENT BIOSOLUTIONS INC. deferred income tax expense (benefit) for the quarter ending 2022-12-31 was -$56.70M, a 233.73% decline year-over-year.
- EMERGENT BIOSOLUTIONS INC. deferred income tax expense (benefit) for the quarter ending 2022-09-30 was $20.40M, a 436.84% increase year-over-year.
- EMERGENT BIOSOLUTIONS INC. deferred income tax expense (benefit) for the quarter ending 2022-06-30 was $700.00K.
- EMERGENT BIOSOLUTIONS INC. deferred income tax expense (benefit) for the quarter ending 2022-03-31 was $1.90M.
- EMERGENT BIOSOLUTIONS INC. deferred income tax expense (benefit) for fiscal 2025 was -$3.90M.
- EMERGENT BIOSOLUTIONS INC. deferred income tax expense (benefit) for fiscal 2024 was -$5.50M.
- EMERGENT BIOSOLUTIONS INC. deferred income tax expense (benefit) for fiscal 2023 was -$7.30M.
- EMERGENT BIOSOLUTIONS INC. deferred income tax expense (benefit) for fiscal 2022 was -$33.70M, a 178.37% decline from fiscal 2021.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 3 month as first filed | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 6 month as first filed | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 9 month as first filed | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | -$3.90M 10-K · filed 2026-02-27 | |||||||
| 2024-12-31 | -$5.50M 10-K · filed 2026-02-27 | |||||||
| 2023-12-31 | -$7.30M 10-K · filed 2026-02-27 | |||||||
| 2022-12-31 | -$56.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | -$36.30M derived: sum of 2 quarters · filed 2025-03-04 | -$35.60M derived: sum of 3 quarters · filed 2025-03-04 | -$33.70M 10-K · filed 2025-03-04 | -$23.90M 10-K · filed 2023-03-01 | |||
| 2022-09-30 | $20.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $21.10M derived: sum of 2 quarters · filed 2022-11-09 | $23.00M 10-Q · filed 2022-11-09 | $65.40M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2022-06-30 | $700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $2.60M 10-Q · filed 2022-08-02 | $45.00M derived: sum of 3 quarters · filed 2024-03-08 | $48.80M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2022-03-31 | $1.90M 10-Q · filed 2022-04-29 | $44.30M derived: sum of 2 quarters · filed 2024-03-08 | $48.10M derived: sum of 3 quarters · filed 2024-03-08 | $46.60M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2021-12-31 | $42.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $46.20M derived: sum of 2 quarters · filed 2024-03-08 | $44.70M derived: sum of 3 quarters · filed 2024-03-08 | $43.00M 10-K · filed 2024-03-08 | $43.90M 10-K · filed 2022-02-25 | |||
| 2021-09-30 | $3.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $2.30M derived: sum of 2 quarters · filed 2022-11-09 | $600.00K 10-Q · filed 2022-11-09 | $1.60M derived: sum of 4 quarters · filed 2023-12-11 | ||||
| 2021-06-30 | -$1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$3.20M 10-Q · filed 2022-08-02 | -$2.20M derived: sum of 3 quarters · filed 2023-12-11 | -$2.90M derived: sum of 4 quarters · filed 2023-12-11 | ||||
| 2021-03-31 | -$1.70M 10-Q · filed 2022-04-29 | -$700.00K derived: sum of 2 quarters · filed 2023-12-11 | -$1.40M derived: sum of 3 quarters · filed 2023-12-11 | -$900.00K derived: sum of 4 quarters · filed 2023-12-11 | ||||
| 2020-12-31 | $1.00M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-12-11 | $300.00K derived: sum of 2 quarters · filed 2023-12-11 | $800.00K derived: sum of 3 quarters · filed 2023-12-11 | -$3.40M 10-K/A · filed 2023-12-11 | -$2.40M 10-K · filed 2021-02-19 | |||
| 2020-09-30 | -$700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | -$200.00K derived: sum of 2 quarters · filed 2021-11-05 | -$4.40M 10-Q · filed 2021-11-05 | $200.00K derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-06-30 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | -$3.70M 10-Q · filed 2021-07-30 | $900.00K derived: sum of 3 quarters · filed 2022-02-25 | -$3.50M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-03-31 | -$4.20M 10-Q · filed 2021-04-30 | $400.00K derived: sum of 2 quarters · filed 2022-02-25 | -$4.00M derived: sum of 3 quarters · filed 2022-02-25 | $6.10M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | $4.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $200.00K derived: sum of 2 quarters · filed 2022-02-25 | $10.30M derived: sum of 3 quarters · filed 2022-02-25 | -$1.10M 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | -$4.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $5.70M derived: sum of 2 quarters · filed 2020-11-06 | -$5.70M 10-Q · filed 2020-11-06 | -$9.90M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2019-06-30 | $10.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | -$1.30M 10-Q · filed 2020-07-31 | -$5.50M derived: sum of 3 quarters · filed 2021-02-19 | -$1.20M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2019-03-31 | -$11.40M 10-Q · filed 2020-05-01 | -$15.60M derived: sum of 2 quarters · filed 2021-02-19 | -$11.30M derived: sum of 3 quarters · filed 2021-02-19 | $1.70M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2018-12-31 | -$4.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $100.00K derived: sum of 2 quarters · filed 2021-02-19 | $13.10M derived: sum of 3 quarters · filed 2021-02-19 | $8.60M 10-K · filed 2021-02-19 | ||||
| 2018-09-30 | $4.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $17.30M derived: sum of 2 quarters · filed 2019-11-07 | $12.80M 10-Q · filed 2019-11-07 | $12.76M 10-Q · filed 2018-11-02 | -$2.52M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-06-30 | $13.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | $8.50M 10-Q · filed 2019-08-02 | $8.47M 10-Q · filed 2018-08-03 | -$6.82M derived: sum of 3 quarters · filed 2020-02-25 | $6.85M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-03-31 | -$4.50M 10-Q · filed 2019-05-08 | -$4.47M 10-Q · filed 2018-05-04 | -$19.82M derived: sum of 2 quarters · filed 2020-02-25 | -$6.15M derived: sum of 3 quarters · filed 2020-02-25 | -$5.50M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2017-12-31 | -$15.32M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$1.65M derived: sum of 2 quarters · filed 2020-02-25 | -$999.00K derived: sum of 3 quarters · filed 2020-02-25 | $3.30M 10-K · filed 2020-02-25 | $3.26M 10-K · filed 2018-02-23 | |||
| 2017-09-30 | $13.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $14.32M derived: sum of 2 quarters · filed 2018-11-02 | $18.62M 10-Q · filed 2018-11-02 | $19.00M derived: sum of 4 quarters · filed 2019-02-22 | ||||
| 2017-06-30 | $652.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $4.95M 10-Q · filed 2018-08-03 | $5.34M derived: sum of 3 quarters · filed 2019-02-22 | $9.60M derived: sum of 4 quarters · filed 2019-02-22 | ||||
| 2017-03-31 | $4.30M 10-Q · filed 2018-05-04 | $4.68M derived: sum of 2 quarters · filed 2019-02-22 | $8.95M derived: sum of 3 quarters · filed 2019-02-22 | $6.54M derived: sum of 4 quarters · filed 2019-02-22 | ||||
| 2016-12-31 | $386.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $4.65M derived: sum of 2 quarters · filed 2019-02-22 | $2.24M derived: sum of 3 quarters · filed 2019-02-22 | $5.20M 10-K · filed 2019-02-22 | $5.19M 10-K · filed 2017-02-28 | |||
| 2016-09-30 | $4.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $1.85M derived: sum of 2 quarters · filed 2017-11-03 | $4.81M 10-Q · filed 2017-11-03 | -$7.63M derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2016-06-30 | -$2.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $547.00K 10-Q · filed 2017-08-04 | -$11.89M derived: sum of 3 quarters · filed 2018-02-23 | $3.38M derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2016-03-31 | $2.96M 10-Q · filed 2017-05-05 | -$9.48M derived: sum of 2 quarters · filed 2018-02-23 | $5.80M derived: sum of 3 quarters · filed 2018-02-23 | $13.69M derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2015-12-31 | -$12.44M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $2.83M derived: sum of 2 quarters · filed 2018-02-23 | $10.72M derived: sum of 3 quarters · filed 2018-02-23 | $3.46M 10-K · filed 2018-02-23 | ||||
| 2015-09-30 | $15.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $23.16M derived: sum of 2 quarters · filed 2016-11-09 | $15.90M 10-Q · filed 2016-11-09 | $30.58M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | $7.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $630.00K 10-Q · filed 2016-08-05 | $15.31M derived: sum of 3 quarters · filed 2017-02-28 | $22.32M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | -$7.26M 10-Q · filed 2016-05-06 | $7.42M derived: sum of 2 quarters · filed 2017-02-28 | $14.43M derived: sum of 3 quarters · filed 2017-02-28 | $17.28M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | $14.68M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $21.69M derived: sum of 2 quarters · filed 2017-02-28 | $24.55M derived: sum of 3 quarters · filed 2017-02-28 | $16.49M 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | $7.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $9.87M derived: sum of 2 quarters · filed 2015-11-06 | $1.82M 10-Q · filed 2015-11-06 | $11.01M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $2.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$5.20M 10-Q · filed 2015-08-06 | $3.99M derived: sum of 3 quarters · filed 2016-02-29 | $8.79M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | -$8.05M 10-Q · filed 2015-05-08 | $1.14M derived: sum of 2 quarters · filed 2016-02-29 | $5.94M derived: sum of 3 quarters · filed 2016-02-29 | $10.32M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $9.19M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $13.99M derived: sum of 2 quarters · filed 2016-02-29 | $18.37M derived: sum of 3 quarters · filed 2016-02-29 | $13.86M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | $4.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $9.18M derived: sum of 2 quarters · filed 2014-11-10 | $4.67M 10-Q · filed 2014-11-10 | -$629.00K derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2013-06-30 | $4.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | -$135.00K 10-Q · filed 2014-08-08 | -$5.43M derived: sum of 3 quarters · filed 2015-03-09 | -$832.00K derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2013-03-31 | -$4.52M 10-Q · filed 2014-05-12 | -$9.81M derived: sum of 2 quarters · filed 2015-03-09 | -$5.21M derived: sum of 3 quarters · filed 2015-03-09 | -$8.08M derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2012-12-31 | -$5.30M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | -$697.00K derived: sum of 2 quarters · filed 2015-03-09 | -$3.56M derived: sum of 3 quarters · filed 2015-03-09 | $3.38M 10-K · filed 2015-03-09 | ||||
| 2012-09-30 | $4.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $1.74M derived: sum of 2 quarters · filed 2013-11-08 | $8.68M 10-Q · filed 2013-11-08 | $16.93M derived: sum of 4 quarters · filed 2014-03-10 | ||||
| 2012-06-30 | -$2.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $4.08M 10-Q · filed 2013-08-06 | $12.33M derived: sum of 3 quarters · filed 2014-03-10 | $21.14M derived: sum of 4 quarters · filed 2014-03-10 | ||||
| 2012-03-31 | $6.94M 10-Q · filed 2013-05-03 | $15.20M derived: sum of 2 quarters · filed 2014-03-10 | $24.00M derived: sum of 3 quarters · filed 2014-03-10 | $24.25M derived: sum of 4 quarters · filed 2014-03-10 | ||||
| 2011-12-31 | $8.25M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10 | $17.06M derived: sum of 2 quarters · filed 2014-03-10 | $17.31M derived: sum of 3 quarters · filed 2014-03-10 | $20.19M 10-K · filed 2014-03-10 | ||||
| 2011-09-30 | $8.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $9.06M derived: sum of 2 quarters · filed 2012-11-01 | $11.94M 10-Q · filed 2012-11-01 | $16.65M derived: sum of 4 quarters · filed 2013-03-08 | ||||
| 2011-06-30 | $250.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $3.13M 10-Q · filed 2012-08-03 | $7.84M derived: sum of 3 quarters · filed 2013-03-08 | $8.92M derived: sum of 4 quarters · filed 2013-03-08 | ||||
| 2011-03-31 | $2.88M 10-Q · filed 2012-05-04 | $7.59M derived: sum of 2 quarters · filed 2013-03-08 | $8.67M derived: sum of 3 quarters · filed 2013-03-08 | |||||
| 2010-12-31 | $4.71M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08 | $5.79M derived: sum of 2 quarters · filed 2013-03-08 | $9.23M 10-K · filed 2013-03-08 | |||||
| 2010-09-30 | $1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $4.52M 10-Q · filed 2011-11-04 | ||||||
| 2010-06-30 | $3.44M 10-Q · filed 2011-08-05 | |||||||
| 2009-12-31 | $5.75M 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |